| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.58 | 0.03 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.066 | 0.03 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.099 | 0.03 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |